Page last updated: 2024-08-25

voriconazole and Atypical Mycobacterial Infection, Disseminated

voriconazole has been researched along with Atypical Mycobacterial Infection, Disseminated in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (80.00)	2.80

Authors

Authors	Studies
Kakizaki, H; Sarbajna, T; Takahashi, Y; Vaidya, A	1
Akata, K; Fukuda, K; Fukuda, Y; Ikegami, H; Ikushima, I; Kawanami, T; Nakamura, M; Noguchi, S; Yamasaki, K; Yatera, K	1
Kanai, T; Kashiwa, Y; Kawahara, K; Kim, SH; Matsuoka, H; Morishita, H; Noda, Y; Samejima, Y; Shimizu, K; Tamura, K; Ueda, K; Umakoshi, T; Yaguchi, T	1
Gao, W; Lu, H; Wang, H; Wu, G; Yang, C; Yuan, C	1
Iseman, MD; Peloquin, CA; Schwiesow, JN	1

Reviews

1 review(s) available for voriconazole and Atypical Mycobacterial Infection, Disseminated

Article	Year
Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review. Internal medicine (Tokyo, Japan), 2020, Jun-01, Volume: 59, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Coinfection; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole	2020

Article

Year

Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review.

Internal medicine (Tokyo, Japan), 2020, Jun-01, Volume: 59, Issue:11

Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Coinfection; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole

2020

Other Studies

4 other study(ies) available for voriconazole and Atypical Mycobacterial Infection, Disseminated

Article	Year
Orbit (Amsterdam, Netherlands), 2020, Volume: 39, Issue:6 Topics: Administration, Ophthalmic; Administration, Oral; Adult; Aspergillosis; Aspergillus; Ciprofloxacin; Coinfection; Conjunctiva; Corynebacterium; Corynebacterium Infections; Dacryocystorhinostomy; Drug Therapy, Combination; Female; Humans; Intubation; Lacrimal Duct Obstruction; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Prostheses and Implants; Retrospective Studies; Slit Lamp Microscopy; Voriconazole	2020
Invasive Tracheobronchial Aspergillosis with Bronchial Ulcers Complicated by Nontuberculous Mycobacterial Disease. Internal medicine (Tokyo, Japan), 2020, May-01, Volume: 59, Issue:9 Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchial Diseases; Bronchoscopy; Diagnosis, Differential; Humans; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ulcer; Voriconazole	2020
Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection. BMC infectious diseases, 2020, Mar-12, Volume: 20, Issue:1 Topics: Adult; Blood Culture; Cefoperazone; China; DNA, Ribosomal; Humans; Linezolid; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Sulbactam; Voriconazole	2020
Concomitant use of voriconazole and rifabutin in a patient with multiple infections. Pharmacotherapy, 2008, Volume: 28, Issue:8 Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole	2008